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Cortical and hippocampal network hyperexcitability appears to be an early event in
Alzheimer’s disease (AD) pathogenesis, and may contribute to memory impairment.
It remains unclear if network hyperexcitability precedes memory impairment in mouse
models of AD and what are the underlying cellular mechanisms. We thus evaluated
seizure susceptibility and hippocampal network hyperexcitability at ∼3 weeks of
age [prior to amyloid beta (Aβ) plaque deposition, neurofibrillary pathology, and
cognitive impairment] in a triple transgenic mouse model of familial AD (3xTg-AD
mouse) that harbors mutated human Aβ precursor protein (APP), tau and presenilin
1 (PS1) genes. Audiogenic seizures were elicited in a higher proportion of 3xTg-AD
mice compared with wild type (WT) controls. Seizure susceptibility in 3xTg-AD mice
was attenuated either by passive immunization with anti-human APP/Aβ antibody
(6E10) or by blockade of metabotropic glutamate receptor 5 (mGluR5) with the
selective antagonist, 2-methyl-6-(phenylethynyl)pyridine hydrochloride (MPEP). In in vitro
hippocampal slices, suppression of synaptic inhibition with the GABAA receptor
antagonist, bicuculline, induced prolonged epileptiform (>1.5 s in duration) ictal-like
discharges in the CA3 neuronal network in the majority of the slices from 3xTg-AD
mice. In contrast, only short epileptiform (<1.5 s in duration) interictal-like discharges
were observed following bicuculline application in the CA3 region of WT slices. The
ictal-like activity in CA3 region of the hippocampus was significantly reduced in
the 6E10-immunized compared to the saline-treated 3xTg-AD mice. MPEP acutely
suppressed the ictal-like discharges in 3xTg-AD slices. Remarkably, epileptiform
discharge duration positively correlated with intraneuronal human (transgenic) APP/Aβ
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expression in the CA3 region of the hippocampus. Our data suggest that in a mouse
model of familial AD, hypersynchronous network activity underlying seizure susceptibility
precedes Aβ plaque pathology and memory impairment. This early-onset network
hyperexcitability can be suppressed by passive immunization with an anti-human
APP/Aβ antibody and by mGluR5 blockade in 3xTg-AD mice.
Keywords: Alzheimer’s disease, amyloid β precursor protein (APP), amyloid β (Aβ), CA3, epilepsy, hippocampus,
metabotropic glutamate receptor 5 (mGluR5), seizure
INTRODUCTION
Alzheimer’s disease (AD) is a chronic progressive
neurodegenerative disorder characterized by profound cognitive
deficits (Blennow et al., 2006). The hippocampus plays a key role
in learning and memory (Morris et al., 1982; Burgess et al., 2002;
Neves et al., 2008), and is one of the first brain regions affected
by AD pathological hallmarks, i.e., amyloid beta (Aβ) plaques
composed of Aβ peptide and neurofibrillary tangles composed
of abnormally hyperphosphorylated tau protein (Braak and
Braak, 1991, 1995, 1996; Morrison and Hof, 2002). Despite the
considerable progress in deciphering the molecular pathology
underlying neurodegeneration in AD over the last three decades,
current understanding of the physiological basis of memory loss
in AD, the most common cause of dementia, is limited.
In recent years, based primarily on critical evidence
obtained from mouse models of AD, a new hypothesis has
emerged that implicates the role of neuronal hyperexcitability,
hypersynchronous network activity and aberrant hippocampal
network rewiring in memory loss in AD (Palop et al., 2007; Palop
andMucke, 2009; Noebels, 2011; Chin and Scharfman, 2013). It is
well known that AD patients are at increased risk for developing
seizures and epilepsy (Friedman et al., 2012). Early-onset familial
AD, caused by genetic mutations in Aβ precursor protein (APP),
presenilin-1 (PS1), and presenilin-2 (PS2), is associated with a
remarkable 87-fold higher seizure incidence compared to the
general population (Amatniek et al., 2006; Cloyd et al., 2006).
In contrast, the late-onset sporadic AD is associated with a
3-fold rise in seizure incidence (Amatniek et al., 2006; Cloyd
et al., 2006). Seizures and epilepsy are particularly pronounced
in families with presenilin mutations; nearly 30% of such AD
patients display this comorbidity, with nearly 75% suffering from
seizures and epilepsy in cases of particularly aggressive variants
with early-onset AD, i.e., before age 40 (Snider et al., 2005; Larner
and Doran, 2006; Jayadev et al., 2010).
AD is a risk factor for seizures, and seizures in AD are thought
to be a consequence of neurodegeneration (Scarmeas et al.,
2009). However, during the last decade, several mouse model
studies have challenged this idea, and have suggested a different
view regarding the relationship between epileptic seizures and
AD, i.e., instead of being a complication of AD, epileptiform
activity including both convulsive and non-convulsive seizures
may contribute to cognitive impairment and disease progression
in AD (Leonard and McNamara, 2007). In a landmark study,
Palop et al. (2007) reported the presence of frequent epileptiform
activity including spikes and sharp waves, and intermittent
unprovoked seizures involving neocortex and hippocampus
on video electroencephalographic (EEG) recordings in 4–7
month-old human APP mice, J20 (carrying human APP
Swedish and Indiana mutations). At this age, these mice show
behavioral and synaptic deficits but no obvious neuronal loss
(Palop et al., 2007). These data suggested that Aβ deposition
is sufficient to elicit epileptiform activity in the absence of
neurodegeneration. In the same study, epileptic activity was
found to lead to compensatory inhibitory remodeling of the
hippocampal circuitry to counteract network activity imbalances
(Palop et al., 2007). It has been proposed that both the recurrent
seizure activity and compensatory homeostatic responses to
this seizure activity may interfere with normal neuronal and
synaptic functions essential for learning and memory (Leonard
and McNamara, 2007; Palop and Mucke, 2009; Noebels, 2011;
Scharfman, 2012a,b; Chin and Scharfman, 2013).
Besides J20 mice, in recent years, network
hypersynchronization and epileptic activity have been
documented in several other mouse models of AD. Several
transgenic mice that carry human APP mutation(s) resulting in
APP/Aβ overexpression display spontaneous seizures, increased
pro-convulsant-induced seizure susceptibility, sharp wave
discharges (SWDs) or interictal spikes (for review, Born, 2015).
Interestingly, many AD transgenic mouse models carrying
human APP mutation(s) display epileptiform activity and
seizure susceptibility prior to amyloid plaque deposition and
cognitive impairment (Del Vecchio et al., 2004; Minkeviciene
et al., 2009; Westmark et al., 2010; Davis et al., 2014; Bezzina
et al., 2015; Duffy et al., 2015). AD mouse models exhibit
an age-dependent neuropathological process and cognitive
decline. Most of the AD mouse models which harbor human
APP mutation(s) and exhibit early-onset epileptiform activity
and seizure susceptibility have increased intraneuronal human
APP and Aβ prior to extracellular Aβ deposition and amyloid
plaque formation (Oddo et al., 2003a,b; Billings et al., 2005;
Lithner et al., 2011; Stargardt et al., 2015). In human AD brains,
intraneuronal Aβ accumulation also precedes plaque formation
(Gyure et al., 2001; Bossers et al., 2010). In AD transgenic mice,
intraneuronal Aβ has been suggested to contribute to cognitive
impairment prior to amyloid plaque stage (Oddo et al., 2003b;
Billings et al., 2005), and aberrant network excitability may be a
mechanism of this cognitive deficit.
APP, like Aβ, may also be a major contributor to
network hyperexcitability in AD patients and transgenic
mice. Remarkably, genetic suppression of transgenic APP in
a human APP mouse model of AD has been shown to
rescue hypersynchronous network activity (Born et al., 2014).
Additionally, increased seizure risk has been documented in
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patients with APP duplication (Cabrejo et al., 2006) and in Down
syndrome (DS) individuals (carrying 3 copies of the APP gene)
with dementia (Menéndez, 2005).
Intraneuronal APP/Aβ may be the major culprit in the early-
onset network hyperexcitability in AD which may ultimately
contribute to cognitive impairment. Nonetheless, the exact
mechanism of early-onset network hypersynchronization
in AD, remains largely unknown. Also, if intraneuronal
APP/Aβ mediate this hypersynchronous network activity,
the contributory role of APP vs. Aβ and the downstream
effectors remain to be elucidated. In the present study, we
evaluated: (1) if the seizure susceptibility and hippocampal
network hypersynchrony precede extensive neuropathology
and cognitive deficit; and (2) what could be the possible
cellular mechanism(s) underlying epileptic activity in a triple
transgenic mouse model of familial AD. We investigated
network hypersynchrony at 3 weeks of age (prior to amyloid
plaque deposition, neurofibrillary pathology, and cognitive
impairment) in a triple transgenic mouse model of AD
(3xTg-AD) that harbors mutated human APP, tau and PS1 genes
(Oddo et al., 2003b). The earliest cognitive deficits reported
in 3xTg-AD mice are by 2–3 months of age (Davis et al.,
2013; Stevens and Brown, 2015). However, most studies show
cognitive impairment in 3xTg-AD by ∼5 months of age (Oddo
et al., 2003b; Billings et al., 2005). We found that 3xTg-AD
mice exhibit aberrant network activity and enhanced seizure
susceptibility at as early as 3 weeks of age, i.e., before the
appearance of amyloid plaque and neurofibrillary pathologies,
and the onset of memory impairment. Our data indicate that
this early-onset network hyperexcitability in 3xTg-AD mice can
be suppressed by passive immunization with an anti-human
APP/Aβ antibody and by metabotropic glutamate receptor 5
(mGluR5) blockade.
MATERIALS AND METHODS
Animals and Housing
The 3xTg-AD mice represent one of the most biologically
relevant animal models described thus far as these mice
replicate all histopathological and behavioral hallmarks of
AD (Oddo et al., 2003b). The 3xTg-AD mice carry three
AD-related genetic loci: human PS1 M146V, human APPSwe
KM670/671NL and human tau P301L. The steady-state levels
of APP and tau proteins are nearly 3-4-fold and 6-8-fold
higher in these mice as compared to endogenous levels in
wild-type (WT) mice (Oddo et al., 2003a,b). These mice develop
amyloid plaques and neurofibrillary tangle-like pathologies in
a progressive and age-dependent manner, starting at ∼9 and
∼12 months, respectively, but show cognitive impairment as
early as 2–3 months (Oddo et al., 2003b; Billings et al., 2005;
Davis et al., 2013; Stevens and Brown, 2015). Several other aspects
of the pathology in these mice also mimic AD pathophysiological
changes and clinical phenotypes such as neurogenesis and
synaptic plasticity impairments, and cognitive decline, all of
which precede Aβ and tau pathologies (Oddo et al., 2003b;
Billings et al., 2005).
The homozygous 3xTg-AD mice were obtained from Dr.
Frank LaFerla (University of California, Irvine, CA, USA)
through Jackson Laboratory (New Harbor, ME, USA). The
background of the 3xTg-ADmice is a hybrid 129/Sv× C57BL/6.
The non-transgenic WT mice used were from the same strain
and genetic background and were also obtained from Jackson
Laboratory. Mice were group-housed (4 animals per cage)
with a 12:12 h light/dark cycle and with ad libitum access
to food and water. This study was performed on 3-week-
old homozygous 3xTg-AD (n = 147) and WT (n = 42)
male and female mice. The mice were housed and bred as
per the PHS Policy on Human Care and Use of Laboratory
animals. The study protocols were approved by the Institutional
Animal Care and Use Committee (IACUC) at SUNY Downstate
Medical Center (Protocol ID: 13-10391) and the IACUC at
New York State Institute for Basic Research (Protocol Number:
ASP199).
In Vivo Auditory Stimulation
Epileptogenic susceptibility to auditory stimuli was tested as
described before (Zhong et al., 2009, 2010). Briefly, 20–22
day-old 3xTg-AD and WT mice were subjected to auditory
stimulation for 5 min in a plastic cage with a high-pitched
siren (120 dB) from a personal alarm device (TBO-Tech, Bonita
Springs, FL, USA) mounted under a Styrofoam cage cover.
Videos were recorded with a digital camcorder, and were
analyzed by an experimenter blind to the animal genotype or
treatment. Recorded parameters included the percentage of mice
undergoing seizures (including tonic and clonic components,
and status epilepticus) and the time to onset of seizure (latency).
Seizure onset was defined as themoment when amouse collapsed
in convulsion.
To evaluate the effect of passive immunization against human
APP/Aβ, the 14–15 day-old 3xTg-AD mice were injected via
a single intraperitoneal (i.p.) injection with an anti-human
APP/Aβ antibody, 6E10 (Covance, Princeton, NJ, USA), and
audiogenic seizure susceptibility was tested when the mice were
21-day-old. The 6E10, a mouse monoclonal IgG-based antibody,
was generated against amino acid residues 1–16 of human APP;
the epitope lies with amino acids 3–8 of human APP. The
antibody is specific to human APP/Aβ, and recognizes both
precursor forms as well as abnormally processed isoforms of
human APP, i.e., APP, sAPPα, and Aβ. Each litter of animals
was divided into two groups. Animals in one group were injected
i.p. with 40 µL of 0.9% NaCl (Saline), and the second group
was injected with 6E10 (18.4 µg) in saline (40 µL). The dose,
route of administration, and timing of passive immunization
against human APP/Aβ were selected based on a previous study
(Westmark et al., 2010).
For experiments with mGluR5 selective antagonist
2-methyl-6-(phenylethynyl)pyridine hydrochloride (MPEP;
Tocris Bioscience, Minneapolis, MN, USA), each litter of
∼3-week-old 3xTg-AD mice was divided into three groups.
Mice in the first group were injected i.p. with 40 µL of saline;
the second and third groups were injected with 40 µL of saline
containing MPEP at concentrations 25 mg/Kg and 40 mg/Kg,
respectively. MPEP solutions were freshly prepared before the
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injections. Mice were subjected to audiogenic stimulation 30 min
after administration of MPEP or saline.
Hippocampal Slice Preparations
The 3-week-old WT and 3xTg-AD mice were deeply
anesthetized with isoflurane and euthanized via decapitation.
The whole right cerebral hemisphere was immersion-fixed
in 4% paraformaldehyde in 0.1 M phosphate buffered saline
(PBS) for immunohistochemical studies. The hippocampus
was dissected out from the left cerebral hemisphere, and
transverse slices (400-µm-thick) were prepared from the
isolated hippocampus using a vibratome (Lancer Series 1000,
The Vibratome Company, Evergreen, St. Louis, MO, USA), as
described before (Lee et al., 2002; Chuang et al., 2005; Zhong
et al., 2009; Zhao et al., 2011; Osterweil et al., 2013). During
slicing, the hippocampus was submerged in an ice-cold low-
Ca2+/high-Mg2+ buffer containing the following (in mM):
124 NaCl, 26 NaHCO3, 2.5 KCl, 8 MgCl2, 0.5 CaCl2 and
10 D-glucose, continuously bubbled with 95% O2 and 5% CO2.
For electrophysiology, slices were transferred to an interface
recording chamber (Fine Science Tools, Vancouver, BC, Canada)
perfused with artificial CSF (ACSF) consisting of the following
(in mM): 124 NaCl, 26 NaHCO3, 5 KCl, 1.6 MgCl2, 2 CaCl2
and 10 D-glucose, bubbled with 95% O2 and 5% CO2; pH 7.4.
Slices were maintained at 34–36◦C for at least 60 min before
recording.
Electrophysiological Recordings
The electrophysiological techniques were used which have
been described before (Chuang et al., 2005; Zhong et al.,
2009; Zhao et al., 2011). Briefly, current clamp, intracellular
recordings were performed in CA3 pyramidal cells (CA3a and
CA3b sub-regions) using an Axoclamp 2A amplifier (Molecular
Devices, Palo Alto, CA, USA). Microelectrodes were pulled
from thin-walled glass tubes (1 mm outer diameter with glass
filament inside; World Precision Instruments, Sarasota, FL,
USA) using a micropipette puller (Sutter Instruments, Novato,
CA, USA). Microelectrodes were filled with 2 M potassium
acetate (typical resistances, 30–50 MΩ). An oscilloscope
(DSO 400; Gould Instrument Systems, Cleveland, OH, USA)
and a chart recorder (TA240; Gould Instrument Systems,
Cleveland, OH, USA) were used for immediate display of
voltage signals. These signals were digitized and stored in an
Intel Pentium-based computer using Digidata 1322A converter
controlled by pClamp 8 software (Molecular Devices, Palo
Alto, CA, USA). CA3 pyramidal cells studied had stable
resting membrane potentials of ∼−60 mV and overshooting
action potentials. In some instances, hyperpolarizing DC was
injected into the cells to prevent intrinsic firing and identify
network activities as spontaneous rhythmic depolarizations
whose frequency was not affected by membrane potential
changes.
Pharmacological Treatments
Baseline epileptiform activities for WT and 3xTg-AD mouse
hippocampal slices were elicited by continuous bath perfusion
of the GABAA receptor antagonist, bicuculline (50 µM;
Sigma-Aldrich, St. Louis, MO, USA). The effect of the
mGluR5 antagonist, MPEP (50 µM) on bicuculline-induced
prolonged epileptiform (ictal-like) discharges in 3xTg-AD
mice hippocampal slices was evaluated. For the passive
immunization with 6E10 studies, 14–15 day-old 3xTg-AD
mice were injected i.p. with saline or antibody in saline as
described above for audiogenic seizure susceptibility studies, and
hippocampal slices experiments were performed on 21-day-old
mice.
Tissue Processing
The whole right cerebral hemisphere from WT and 3xTg-AD
mice from electrophysiology studies was immediately immersion
fixed in 4% paraformaldehyde in 0.1M PBS for 24–48 h, followed
by cryoprotection in a 30% sucrose solution at 4◦C overnight.
Later, 40 µm-thick sagittal sections were cut on a freezing
microtome. The sections were stored in glycol anti-freeze
solution (ethylene glycol, glycerol, and 0.1 M PBS in a 3:3:4 ratio)
at −20◦C till further processing for immunohistochemical
staining.
Immunohistochemistry
Immunohistochemical studies for evaluation of human APP/Aβ
expression were performed on free-floating brain sections,
as described previously (Kazim et al., 2014; Chohan et al.,
2015; Dai et al., 2015). Every 8–9th brain section was
chosen for densitometric quantification which was carried
out using a minimum of five brain sections/mouse from
five to six animals/group. All stainings for fluorescence intensity
quantification were carried out under similar conditions
including all tissue sections for an experiment stained at the
same time, and imaged using identical laser power and detector
settings. The following primary antibodies at the indicated
dilutions were employed: mouse monoclonal anti-human
APP/Aβ antibody, 6E10 [1:200; recognizes N-terminal amino
acids 1–16 of Aβ peptide (epitope lies within amino acids
3–8 of Aβ), sAPPα, and C-terminal fragment (CTF)β/C99,
and stains human APP and Aβ; Covance, Princeton, NJ,
USA], and rabbit polyclonal anti-human APP antibody, CT20
[1:500; C-terminal (751–770), recognizes full-length APP, and
CTFα, CTFβ, and CTFγ, and stains human APP/CTFs;
EMD Millipore, Billerica, MA, USA]. The following secondary
antibodies were used: Alexa 488-conjugated goat anti-mouse
IgG anti-body (1:500, Molecular Probes, Carlsbad, CA, USA),
and Alexa 488-conjugated goat anti-rabbit IgG antibody (1:500,
Molecular Probes, Carlsbad, CA, USA). Maximum projection
images of the CA3 region of the hippocampus in stained
sections were generated based on confocal z-stacks using Nikon
90i fluorescent microscope equipped with Nikon C1 three-
laser confocal system and a Nikon DS U1 digital camera.
For densitometry, the whole CA3 region was outlined, and
quantified by measuring mean pixel intensity (MPI) with
the software Image Pro Plus 5.0 (Media Cybernetics, Silver
Spring, MD, USA), as described previously (Kazim et al.,
2014).
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Data Analysis
For audiogenic seizure susceptibility experiments, the incidence
of seizures data is presented as percent incidence with 95%
confidence interval, and was analyzed using exact logistic
regression analysis stratified by litter. The latency to seizure
data is depicted as median with range (skewed distribution).
Mann-Whitney U test, or for multiple groups, Kruskal-Wallis
test followed by Dunn’s multiple comparison test, was employed
for analyzing latency data. The D’Agostino-Pearson, Shapiro-
Wilk, and Kolmogorov-Smirnov normality tests were used to
determine if the data was normally distributed or skewed. The
statistical analysis was performed using SAS v.9.4 (SAS Institute,
Cary, NC, USA) and GraphPad Prism v 7.0 (GraphPad Software
Inc., La Jolla, CA, USA). For all purposes, p < 0.05 was
considered as statistically significant.
For electrophysiology data, the durations of individual
synchronized discharges were measured from the beginning
of the first action potential to the repolarization of the last
action potential of the discharge. Membrane potentials were kept
within a few millivolts throughout the experiment. Frequency
histograms included the durations of all synchronized discharges
that were recorded in 5 min periods for each slice under
respective experimental conditions. Based on the frequency
distribution of the synchronized discharges durations observed
in previous studies (Chuang et al., 2005; Zhong et al., 2009),
‘‘short’’ burst discharges refer to synchronized discharges shorter
than or equal to 1.5 s and ‘‘prolonged’’ epileptiform (ictal-
like) discharges to those longer than 1.5 s. In the frequency
histogram plots, the durations of all synchronized epileptiform
discharges recorded in a 5-min period for each slice in the
various experimental conditions were included. The histograms
were fitted with first- or second-order Gaussian equations, as
appropriate. The data on the average durations of the five
longest synchronized discharges at respective time intervals
were analyzed using repeated measures, two-way analysis of
variance (ANOVA) followed by Bonferroni’s post hoc test. The
comparisons involving average duration of the five longest
discharges between study groups were performed using Student’s
t-test. For passive immunization with 6E10 experiments, the data
on percentage of slices with prolonged epileptiform discharges
was analyzed using Fischer’s exact test and chi-square test
with Yates correction. Also, for passive immunization with
6E10 experiments, latency to the occurrence of prolonged
epileptiform discharges was analyzed using Student’s t-test.
Clampfit v.9.2 (Axon Instruments/Molecular Devices, Novato,
CA, USA), SPSS v.17.0 (SPSS Inc., Chicago, IL, USA) and
GraphPad Prism 7.0 (GraphPad Software Inc., LaJolla, CA,
USA) were used for data and statistical analysis. For all
comparisons, p < 0.05 was set as statistical significance
level.
For immunohistochemistry data, MPI was compared using
Student’s t-test. For correlation data, Pearson correlation
coefficient was calculated, and curve fitting was carried out
by employing non-linear regression model. GraphPad Prism
7.0 (GraphPad Software Inc., LaJolla, CA, USA) was used
for statistical analysis, with p < 0.05 considered as statistical
significance level.
RESULTS
Young 3xTg-AD Mice Are Highly
Susceptible to Audiogenic Seizures
In transgenic models of AD, network hypersynchrony and
epileptic susceptibility have been shown to appear prior
to amyloid plaque deposition, neurofibrillary pathology and
cognitive dysfunction (Bezzina et al., 2015; Duffy et al., 2015;
Kam et al., 2016; Shah et al., 2016). To probe for in vivo
epileptogenic susceptibility prior to extensive neuropathology
and cognitive deficit in 3xTg-AD mice, we exposed 3-week-old
mice to 120 dB siren in a single 5-min-session and analyzed the
percentage of animals exhibiting seizure and the latency to the
occurrence of seizure (Figure 1; WT, n = 35; 3xTg-AD, n = 20;
age = 20–22 days).
3xTg-AD mice typically exhibited early indications of
epileptic activity in the form of wild, uncontrolled running
and jumping. This frenzied, excessive motor activity was the
first sign of imminent convulsive seizure. A remarkably higher
percentage of 3xTg-ADmice (90%, 18 out of 20) developed tonic-
clonic convulsive seizures as compared to WT controls (8.6%,
3 out of 35) within 1 min of the onset of alarm (Figure 1A;
p < 0.001, exact logistic regression stratified by litter). In
mice that developed convulsive seizures, the latency to the
occurrence of seizures was markedly lower in 3xTg-AD mice as
compared to WT mice (Figure 1B; p = 0.0038; Mann-Whitney
U test).
These data show that: (1) young 3xTg-AD mice harboring
mutated APP, tau and PS1 genes are acutely susceptible
to audiogenic seizures; and (2) epileptogenic vulnerability
appears before overt cognitive impairment and much before
the development of extensive AD neuropathology in these
mice.
FIGURE 1 | Increased propensity for audiogenic seizures in 3-week-old
triple transgenic mouse model of familial Alzheimer’s disease
(3xTg-AD) mice. (A) The incidence of convulsive seizures was markedly
higher in 3xTg-AD mice (blue bar) compared to wild type (WT) mice (red bar).
The data are presented as percent incidence with 95% confidence interval
and compared using exact logistic regression stratified by litter. (B) The
latency to seizure was significantly lower in 3xTg-AD mice as compared to WT
control. The data are depicted as median with range, and analyzed using
Mann-Whitney U test. ∗∗p < 0.01, ∗∗∗p < 0.001, compared to WT. WT
(n = 35) and 3xTg-AD (n = 20) mice.
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Young 3xTg-AD Mice Exhibit
Hyperexcitability of the Hippocampal
CA3 Neuronal Network
The earliest neuropathological changes in AD occur in the
hippocampus and entorhinal cortex, followed by changes in the
medial temporal lobe (Belleville et al., 2008; Reitz et al., 2009;
Small et al., 2011). Correspondingly, the earliest known cognitive
deficit in AD is in the hippocampus-dependent episodic memory
including its crucial features, pattern separation and pattern
completion (Collie and Maruff, 2000; Ally et al., 2013). The
CA3 region of the hippocampus is known to play a major
role in both pattern separation and pattern completion (Yassa
and Stark, 2011). We thus evaluated the CA3 pyramidal
neuronal excitability and epileptogenic susceptibility using
pharmacological disinhibition of hippocampal slices as an
in vitro model of epileptogenesis (Chuang et al., 2005).
Intracellular recordings were carried out in CA3 pyramidal
neurons of hippocampal slice preparations isolated from
3-week-old 3xTg-AD mice and their WT controls (Figure 2).
Spontaneous epileptiform discharges were elicited by application
of the GABAA receptor antagonist, bicuculline. Previous studies
have shown that in slices from WT animals, this treatment
typically induces short (≤1.5 s in duration), interictal-like
epileptiform discharges (Prince and Wong, 1981; Chuang et al.,
2005), whereas in slices from transgenic mice that exhibit
enhanced seizure susceptibility bicuculline can induce prolonged
(>1.5 s), ictal-like epileptiform discharges (Chuang et al., 2005;
Zhong et al., 2009, 2010).
Bath application of bicuculline (50 µM) to hippocampal
slice preparations prepared from WT mice (n = 11 slices
from n = 7 mice) caused the appearance, within 20 min,
of regular and rhythmic short synchronized discharges (mean
duration = 0.215± 0.004 s) in the CA3 area (Figures 2A,C). The
duration of short synchronized discharges remained ≤ 1.5 s for
at least 1 h in all WT slice preparations studied (Figures 2A,C).
The average duration of short synchronized discharges recorded
60 min after bicuculline application was 0.560 ± 0.017 s
(Figure 2Ca; first-order Gaussian fit; r = 0.81). The average
durations of the five longest synchronized discharges during
a 5-min-period recorded 60 min after bicuculline application
in WT slices were significantly prolonged as compared to
those recorded after 20 min (Figure 2Cb; p = 0.016, repeated
measures, two-way ANOVA). However, no prolonged ictal-like
epileptiform discharge (>1.5 s) was observed during the period
of recording in WT slices.
Figures 2B,D depicts data obtained from hippocampal
slices prepared from 3xTg-AD mice (n = 9 slices from
n = 6 mice). Like in WT slices, bicuculline (50 µM)
application induced rhythmic, short interictal-like epileptiform
discharges. The average duration of these short epileptiform
synchronized discharges 20 min after bicuculline application
was 0.395 ± 0.008 s. Hippocampal slices from the majority of
3xTg-ADmice (5/6, 83.3%) started to show a distinct population
of prolonged ictal-like epileptiform discharges (>1.5 s) about
30 min after bicuculline application (Figures 2B,D). The
average duration of these prolonged epileptiform discharges
was 4.664 ± 0.204 s as compared to the mean duration
of 0.576 ± 0.024 s of the population of short epileptiform
discharges (Figure 2Da; second-order Gaussian fit; r = 0.79). The
average durations of the five longest synchronized epileptiform
discharges recorded during 5-min periods after 60 min of
bicuculline perfusion were significantly prolonged compared
to those recorded after 20 min of bicuculline (Figure 2Db;
p < 0.001, repeated measures, two-way ANOVA). Also,
the average duration of five longest epileptiform discharges
during 5-min periods after 60 min of bicuculline was
significantly higher in slices from 3xTg-AD mice as compared
to WT controls (p = 0.0006; Student’s t-test). These data
indicate that at 3 weeks of age, 3xTg-AD mice exhibit
marked hippocampal CA3 neuronal hypersynchronous, ictal-like
activity.
Expression of Intraneuronal Human
APP/Aβ Is Seen in the Hippocampal
CA3 Region of Young 3xTg-AD Mice
The 3xTg-AD mice carry a 3–4 fold APP overexpression
(Oddo et al., 2003a). The intraneuronal human APP/Aβ
immunoreactivity in the CA fields of the hippocampus has
been documented in 3xTg-AD mice as early as 3 weeks of
age (Billings et al., 2005; Oh et al., 2010). We evaluated
the human APP/Aβ expression in the CA3 region of the
hippocampus in 3-week-old 3xTg-AD mice and WT controls
by employing two different antibodies (Figure 3). First, we
used anti-APP/Aβ antibody, 6E10, which recognizes N-terminal
amino acids 1–16 of the Aβ peptide and stains human
APP and Aβ. The 6E10 antibody also recognizes sAPPα and
CTFβ, C99 (Chang et al., 2003). The 6E10 staining revealed
immunoreactive neurons in the CA3 region of 3-week-old
3xTg-AD mice, and as expected, the WT mice failed to
show immunoreactivity (Figures 3A,B; p < 0.001, Student’s t-
test). Second, we employed anti-human APP antibody, APP-
CT20, which recognizes full-length APP and CTFs. Like
6E10, the APP-CT20 staining showed immunoreactivity in the
CA3 region of 3-week-old 3xTg-AD mice, and not in WT mice
(Figures 3C,D; p< 0.001, Student’s t-test).
Taken together, these data confirmed the intraneuronal
human APP/Aβ immunoreactivity as early as 3 weeks of age
in 3xTg-AD mice. As expected, no extracellular amyloid plaque
deposits were found at this age in 3xTg-AD mice.
Passive Immunization with the Anti-Human
APP/Aβ Antibody, 6E10, Attenuates Seizure
Susceptibility in Young 3xTg-AD Mice
Genetic suppression of transgenic human APP was shown
to suppress hypersynchronous network activity in an AD
mouse model (Born et al., 2014). Also, intraneuronal Aβ
accumulation was reported to induce hippocampal neuron
hyperexcitability (Scala et al., 2015). We thus sought to
determine if pharmacological clearance of intraneuronal human
APP/Aβ could ameliorate the seizure susceptibility in young
3xTg-AD mice. We assessed audiogenic seizure rate after
passive immunization with an anti-human APP/Aβ monoclonal
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FIGURE 2 | Ictal-like epileptiform discharges in CA3 pyramidal cells of hippocampal slices from 3-week-old 3xTg-AD mice. (A) CA3 intracellular
recording from a WT slice after bicuculline addition (50 µM). Within 20 min, bicuculline induced rhythmic, short epileptiform discharges (≤1.5 s in duration) that were
ongoing for at least 1 h of continuous recording. A representative trace of short epileptiform discharges from a WT slice at 60 min after bicuculline application is
shown in (Aa). Membrane potential at the beginning of recording: −60 mV. (Ab) Plot of the duration of discharges recorded in the cell shown in (Aa).
(B) CA3 intracellular recording from a 3xTg-AD slice after bicuculline. Bicuculline first induced short synchronized epileptiform discharges that were like those in WT
slices. However, continuous perfusion with bicuculline induced prolonged epileptiform (ictal-like) discharges (>1.5 s) in 3xTg-AD slice (Ba). Membrane potential at
the beginning of recording: −65 mV. (Bb) Plot of the duration of discharges recorded in the cell shown in (Ba). (Ca) Frequency histogram of the duration of all
epileptiform discharges during a 5-min period after 60 min of bicuculline perfusion in WT mice (n = 7 mice, n = 11 slices). In WT slices, epileptiform discharges were
normally distributed with an average duration of 0.560 ± 0.017 s (first-order Gaussian fit; r = 0.81). No prolonged epileptiform discharge was observed in WT slices.
(Cb) The average duration of the five longest synchronized epileptiform discharges recorded during 5-min intervals at 20 min (0.267 ± 0.021 s) and 60 min
(0.636 ± 0.114 s) after bicuculline application in WT slices. The short epileptiform discharges increased in duration significantly over the time course of the recordings
in WT slices, however, no prolonged discharge (>1.5 s) was observed. (Da) Frequency histogram of the duration of all synchronized epileptiform discharges during a
5-min-period after 60 min of bicuculline perfusion in 3xTg-AD mice (n = 6 mice, n = 9 slices). A two-peak distribution showed a group of short epileptiform
discharges with average duration of 0.572 ± 0.024 s and a group of prolonged epileptiform discharges of 4.664 ± 0.204 s (second-order Gaussian fit; r = 0.79).
(Db) The average duration of the five longest synchronized discharges recorded during 5 min intervals after 60 min (4.497 ± 0.869) was significantly higher than that
after 20 min (0.521 ± 0.051) of bicuculline perfusion. ∗p < 0.05, ∗∗∗p < 0.001, repeated measures two-way analysis of variance (ANOVA).
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FIGURE 3 | Expression of intraneuronal human amyloid β precursor
protein (APP)/amyloid beta (Aβ) in the hippocampal CA3 region of
3-week-old 3xTg-AD mice. (A) Representative photomicrographs showing
6E10 (human APP/Aβ) intraneuronal expression in the hippocampal
CA3 region of 3-week-old 3xTg-AD mice; as expected WT mice did not
display 6E10 immunoreactivity. No extracellular amyloid plaque deposition
was observed. (B) Densitometric quantification of the immunohistochemistry
data with 6E10 expression. (C) Representative photomicrographs showing
APP-CT20 (human APP/C-terminal fragments, CTFs) intraneuronal expression
in the hippocampal CA3 region of 3-week-old 3xTg-AD mice; no expression is
observed in WT mice. (D) Densitometric quantification of the
immunohistochemistry data with APP-CT20 expression. The data are shown
as mean ± SEM from WT (n = 5) and 3xTg-AD (n = 6), and compared using
Student’s t-test. Insets show the designated areas at higher magnification.
Scale bar = 100 µm. ∗∗∗p < 0.001.
FIGURE 4 | Attenuation of audiogenic seizure susceptibility by passive
immunization with anti-human APP/Aβ antibody, 6E10, in 3-week-old
3xTg-AD mice. (A) The incidence of convulsive seizures in 3xTg-AD mice
was significantly reduced by passive immunization with 6E10. The data are
presented as percent incidence with 95% confidence interval and compared
using exact logistic regression stratified by litter. (B) Passive immunization with
6E10 also significantly increased the latency to seizure in 3xTg-AD mice. The
data are depicted as median with range, and analyzed using Mann-Whitney U
test. ∗∗p < 0.01, ∗∗∗p < 0.001, compared to Saline-3xTg-AD. Saline-3xTg-AD
(n = 23) and 6E10–3xTg-AD (n = 22) mice.
antibody, 6E10, in 3-week-old 3xTg-AD mice (Figure 4; Saline-
3xTg-AD, n = 23, 6E10–3xTg-AD, n = 22).
Passive immunization with 6E10 significantly reduced the
seizure incidence in 3-week-old 3xTg-AD mice (Figure 4A;
p < 0.01; exact logistic regression stratified by litter). Passive
immunization with 6E10 also increased significantly the latency
to convulsive seizures (Figure 4B; p < 0.001, Mann-Whitney
U test). Overall, these data suggest that passive immunization
against humanAPP/Aβ decreases the susceptibility to audiogenic
seizures in young 3xTg-AD mice.
Passive Immunization with Anti-Human
APP/Aβ Antibody, 6E10, Decreases
Intraneuronal Human APP/Aβ Expression
in Young 3xTg-AD Mice
Previously, treatment with 6E10 was demonstrated to reduce
intraneuronal human Aβ and cell-surface full-length APP
in cultured neurons from Tg2576 mice carrying hAPPSWE
mutation (Tampellini et al., 2007). We evaluated the effect
of passive immunization with 6E10 on human APP/Aβ
expression in the hippocampal CA3 neurons of 3-week-old
3xTg-ADmice (Figure 5). Densitometric quantification revealed
that passive immunization with 6E10 significantly reduced
human APP/Aβ expression, as analyzed by 6E10 expression,
in the CA3 region of young 3xTg-AD mice (Figures 5A,B;
p = 0.0023, Student’s t-test). Furthermore, APP-CT20
staining also revealed a significant reduction in human
APP/CTFs expression (Figures 5C,D; p = 0.0228, Student’s
t-test). These data suggest that 6E10 passive immunization-
induced reduction in seizure susceptibility in young 3xTg-AD
FIGURE 5 | Reduction in intraneuronal human APP/Aβ expression by
passive immunization with anti-human APP/Aβ antibody, 6E10, in the
hippocampal CA3 region of 3-week-old 3xTg-AD mice.
(A) Representative photomicrographs illustrating reduction in 6E10 (human
APP/Aβ) intraneuronal immunoreactivity in the hippocampal CA3 region of
young 3xTg-AD mice after passive immunization with 6E10. (B) Densitometric
quantification of the immunohistochemistry data with 6E10 expression.
(C) Representative photomicrographs showing decrease in APP-CT20
(human APP/CTFs) intraneuronal expression in the hippocampal CA3 region of
young 3xTg-AD mice after passive immunization with 6E10. (D) Densitometric
quantification of the immunohistochemistry data with APP-CT20 expression.
The data are shown as mean ± SEM from Saline-3xTg-AD (n = 9) and
6E10–3xTg-AD (n = 9), and compared using Student’s t-test. Insets show the
designated areas at higher magnification. Scale bar = 100 µm. ∗p < 0.05,
∗∗p < 0.01.
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mice may result from the reduction in transgenic human
APP/Aβ.
Passive Immunization with Anti-Human
APP/Aβ Antibody, 6E10, Reduces Ictal-Like
Activity in Hippocampal Slices from Young
3xTg-AD Mice
We further evaluated the effect of passive immunization with
anti-human APP/Aβ antibody, 6E10, on ictal-like activity in
the CA3 pyramidal neurons of the hippocampal slices from
3-week-old 3xTg-AD mice (Figure 6). CA3 intracellular
recordings revealed that bath application of bicuculline
(50 µM) to hippocampal slice preparations from Saline-
3xTg-AD mice (n = 22 slices from n = 9 mice) induced
regular and rhythmic short epileptiform discharges (mean
duration = 0.345 ± 0.006 s) within 20 min (Figures 6A,C).
Prolonged epileptiform discharges (>1.5 s) started appearing
at >30 min after bicuculline application in the majority of
slices from Saline-3xTg-AD mice (Figures 6A,C). At 60 min
after bicuculline, a two-peak distribution showed a group
of short epileptiform discharges with average duration of
0.560 ± 0.015 s and a group of prolonged epileptiform
discharges of 4.339 ± 0.086 s (second-order Gaussian fit;
r = 0.79; Figure 6Ca). Also, at 90 min after bicuculline, a
two-peak distribution showed a group of short epileptiform
discharges with average duration of 0.553 ± 0.018 s and a
group of prolonged epileptiform discharges of 4.951 ± 0.079 s
(second-order Gaussian fit; r = 0.83; Figure 6Cb). The average
durations of the five longest synchronized discharges from
Saline-3xTg-AD mice recorded during 5-min periods after
60 min (4.369 ± 0.540 s; Figure 6Fa, blue bar) and 90 min
(4.594 ± 0.552 s; Figure 6Fb, blue bar) were significantly longer
than those after 20 min (0.301± 0.025 s) of bicuculline perfusion
(p< 0.001, repeated measures, two-way ANOVA).
Remarkably, in contrast to slices from saline injected
3xTg-AD mice, none of the slices from 6E10–3xTg-AD mice
(n = 23 slices from n = 9 mice) exhibited prolonged
epileptiform discharges 60 min after bicuculline application
(Figures 6B,D,Ea; mean duration = 0.475 ± 0.010 s, first-
order Gaussian fit; r = 0.91). However, 90 min after bicuculline
application, 34.8% of the slices from 6E10–3xTg-AD mice
developed prolonged epileptiform discharges (Figures 6B,D,Eb).
At 90 min after bicuculline, a two-peak distribution showed a
group of short epileptiform discharges with average duration
of 0.466 ± 0.016 s and a group of prolonged epileptiform
discharges of 4.195 ± 0.168 s (second-order Gaussian fit;
r = 0.88; Figure 6Db). The average duration of the five longest
synchronized epileptiform discharges from 6E10–3xTg-ADmice
recorded during a 5-min-period after 90 min (2.232 ± 0.747 s;
Figure 6Fb, brown bar) was significantly longer than those after
20min (0.297± 0.020 s) and 60min (0.440± 0.041 s; Figure 6Fa,
brown bar) of bicuculline perfusion (p< 0.01, repeatedmeasures,
two-way ANOVA).
The overall incidence of bicuculline-induced prolonged
epileptiform discharges was significantly reduced by passive
immunization with 6E10 (Figure 6Ea; 60 min after bicuculline:
18 out of 22 (81.8%) slices from Saline-3xTg-AD mice (n = 9)
vs. 0 out of 23 (0%) slices from 6E10–3xTg-AD mice (n = 9),
Fischer’s exact test, p < 0.001, Chi-square test with Yates
correction, p < 0.001; Figure 6Eb; 90 min after bicuculline:
18 out of 22 (81.8%) slices from Saline-3xTg-AD mice (n = 9)
vs. 8 out of 23 (34.8%) slices from 6E10–3xTg-AD mice (n = 9),
Fischer’s exact test, p = 0.0023, Chi-square test with Yates
correction, p = 0.0038).
Passive immunization with 6E10 significantly reduced the
average of the five longest epileptiform discharges both at 60 and
90 min time points after bicuculline application (Figures 6Fa,b;
bicuculline 60 min, Saline-3xTg-AD, 4.369 ± 0.545 s, vs.
6E10–3xTg-AD, 0.440 ± 0.041 s, p < 0.001, Student’s t-test;
and bicuculline 90 min, Saline-3xTg-AD, 4.954 ± 0.552 s, vs.
6E10–3xTg-AD, 2.232 ± 0.747, p = 0.021; Student’s t-test).
Remarkably, in the slices that developed prolonged epileptiform
discharges, passive immunization with 6E10 significantly
increased the latency to the occurrence of these discharges
(Figure 6G; Saline-3xTg-AD mice, 37.3 ± 1.7 min, vs.
6E10–3xTg-AD mice, 85.2 ± 4.8 min; p < 0.001, Student’s
t-test).
Overall, these data show that passive immunization with
anti-human APP/Aβ antibody, 6E10, significantly reduced
ictal-like activity in the CA3 neuronal network of the
hippocampus. The delay in the appearance of prolonged
epileptiform discharges in some of the 6E10-injected 3xTg-AD
mice may suggest a role for intraneuronal human APP/Aβ in the
induction of hypersynchronous network activity.
The Ictal-Like Activity in CA3 Hippocampal
Region Correlates Positively with
Intraneuronal APP/Aβ Expression in Young
3xTg-AD Mice
To further evaluate the role of human APP/Aβ in epileptiform
activities in 3-week-old 3xTg-ADmice, we performed correlation
analyses between the duration of the epileptiform discharges
recorded from CA3 neurons and the human APP/Aβ expression
level in the CA3 region in the brains of the same mice.
The data from the Saline-3xTg-AD and 6E10–3xTg-AD mice
were pooled together for the correlation analyses. We found
a significant positive correlation between intraneuronal human
APP/Aβ expression level (both 6E10 and APP-CT20) and
ictal-like activity (Figures 7A,B; 6E10 expression and ictal-like
activity, Pearson correlation coefficient, r = 0.9152, p < 0.001;
APP-CT20 expression and ictal-like activity, Pearson correlation
coefficient, r = 0.6893, p < 0.001). These data strongly support
the role of human (transgenic) APP/Aβ in ictal-like activity in
young 3xTg-AD mice.
The mGluR5 Antagonist MPEP Suppresses
Convulsive Audiogenic Seizures in Young
3xTg-AD Mice
Our above data indicate that intraneuronal human APP/Aβ is
a likely cause of neuronal hyperexcitability and propensity to
epileptic seizures in young 3xTg-AD mice. Activation of the
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FIGURE 6 | Suppression of ictal-like activity by passive immunization with anti-human APP/Aβ antibody, 6E10, in hippocampal slices from
3-week-old 3xTg-AD mice. (A) CA3 intracellular recordings from a Saline-3xTg-AD slice after bicuculline application (50 µM). Continuous perfusion with bicuculline
induced prolonged synchronized epileptiform discharges (>1.5 s) in Saline-3xTg-AD slice which are depicted at 60 min (AaI) and 90 min (AaII) after bicuculline
application. Membrane potential at the beginning of recordings: −73 mV (60 min) and −75 mV (90 min). (Ab) Plot of the duration of epileptiform discharges recorded
in the cell shown in (Aa). (B) CA3 intracellular recordings from a 6E10–3xTg-AD slice revealed only short epileptiform discharges 60 min after bicuculline application
(BaI). Fully developed prolonged epileptiform discharges were not observed until 90 min after bicuculline (BaII). Membrane potential at the beginning of recordings:
−76 mV (60 min) and −74 mV (90 min). (Bb) Plot of the duration of epileptiform discharges recorded in the cell shown in (Ba). (C) Frequency histograms of the
duration of all synchronized discharges during a 5-min period after 60 min (Ca) and 90 min (Cb) of bicuculline perfusion in Saline-3xTg-AD mice (n = 22 slices from
n = 9 mice). At 60 min after bicuculline, a two-peak distribution showed a group of short epileptiform discharges with average duration of 0.560 ± 0.015 s and a
group of prolonged epileptiform discharges of 4.339 ± 0.086 s (second-order Gaussian fit; r = 0.79). Also, at 90 min after bicuculline, a two-peak distribution
showed a group of short epileptiform discharges with average duration of 0.553 ± 0.018 s and a group of prolonged epileptiform discharges of 4.951 ± 0.079 s
(second-order Gaussian fit; r = 0.83). (D) Frequency histograms of the duration of all epileptiform discharges during a 5-min period after 60 min (Da) and 90 min
(Db) of bicuculline perfusion in 6E10–3xTg-AD mice (n = 23 slices from n = 9 mice). At the 60-min time point, all epileptiform discharges were normally distributed
with an average duration of 0.475 ± 0.011 s (first-order Gaussian fit; r = 0.91). No prolonged epileptiform discharge was observed in Saline-3xTg-AD mice at 60 min
after bicuculline application. However, some of the slices (8 out of 23, 34.8%) exhibited long epileptiform discharges 90 min after bicuculline. At 90 min after
bicuculline, a two-peak distribution showed a group of short epileptiform discharges with average duration of 0.466 ± 0.016 s and a group of prolonged epileptiform
discharges of 4.195 ± 0.168 s (second-order Gaussian fit; r = 0.88). (E) The overall incidence of prolonged epileptiform discharges both 60 min (Ea) and 90 min
(Eb) after bicuculline application was significantly reduced by passive immunization with 6E10 (p < 0.001 and p = 0.0023, respectively; Fischer’s exact test).
(F) Passive immunization with 6E10 significantly reduced the average durations of the five longest synchronized epileptiform discharges recorded during 5 min
intervals both 60 min (Fa) and 90 min (Fb) after bicuculline (p < 0.001 and p = 0.021, respectively; Student’s t-test). (G) The latency to occurrence of prolonged
epileptiform discharges was significantly higher in 6E10–3xTg-AD mice (85.3 ± 4.8 min) as compared to Saline-3xTg-AD mice (37.2 ± 1.7 min; p < 0.001; Student’s
t-test). ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001.
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FIGURE 7 | Positive correlation of intraneuronal human APP/Aβ
expression in CA3 neurons and ictal-like activity in CA3 region.
(A,B) Correlation analyses revealed a positive relationship between
intraneuronal human APP/Aβ immunoreactivity in the CA3 neurons (analyzed
by 6E10, human APP/Aβ (A) and by APP-CT20, human APP/CTFs (B)) and
average duration of the five longest epileptiform discharges recorded during a
5-min period after 90 min of bicuculline application in CA3 region of
hippocampal slices from the same mice. Data from Saline-3xTg-AD (n = 9)
and 6E10–3xTg-AD (n = 9) was pooled together to evaluate the correlations
depicted in (A,B). The sigmoidal curves based on non-linear regression are
also shown.
mGluR5 has been shown to increase translation of APP mRNA
(Westmark and Malter, 2007; Sokol et al., 2011; Westmark,
2013). The mGluR5 activation is also known to mediate Aβ
oligomer-induced neuronal and synaptic dysfunction (Renner
et al., 2010; Um et al., 2013). Blockade of mGuR5 with the
noncompetitive antagonist MPEP which can cross the blood-
brain barrier (Gasparini et al., 1999; Varney et al., 1999) has been
shown to attenuate seizure susceptibility in mouse models of AD
and DS (Westmark et al., 2010), and fragile X syndrome (FXS;
Yan et al., 2005; Westmark et al., 2009, 2010; Zhong et al., 2009).
We thus evaluated the effect of MPEP on audiogenic seizure
susceptibility to determine whether mGluR5 activation plays a
role in this ictal-like activity mediated behavioral phenotype in
3-week-old 3xTg-AD mice (Figures 8A,B).
We administered i.p. MPEP 30 min before auditory
stimulation. MPEP-injected 3xTg-AD mice exhibited a decrease
in the incidence of audiogenic seizures (Figure 8A; MPEP
25 mg/Kg, p < 0.01; MPEP 40 mg/Kg, p < 0.01; exact logistic
regression stratified by litter). MPEP-injected 3xTg-AD mice
exhibited a significant, dose-dependent increase in the latency
to occurrence of convulsive seizures as compared to saline-
treated controls (Figure 8B; MPEP 25 mg/Kg, p < 0.05;
MPEP 40 mg/Kg, p < 0.001; Kruskal-Wallis test followed by
Dunn’s multiple comparison test). Overall, these data show
that the mGluR5 antagonist MPEP attenuates epileptic seizure
susceptibility in 3-week-old 3xTg-AD mice.
MPEP Suppresses Prolonged Epileptiform
Discharges in Hippocampal Slices from
Young 3xTg-AD Mice
We next examined the effect of MPEP on prolonged epileptiform
discharges elicited by bicuculline in hippocampal slices from
young 3xTg-AD mice (Figures 8C,D). Prolonged epileptiform
discharges were observed after extended (>30 min) exposure
to bicuculline in 3xTg-AD hippocampal slices (Figures 8C,D;
average duration of the five longest epileptiform discharges,
FIGURE 8 | Suppression of seizure susceptibility and prolonged
epileptiform discharges in hippocampal slices of 3-week-old 3xTg-AD
mice by the metabotropic glutamate receptor 5 (mGluR5) antagonist
2-methyl-6-(phenylethynyl)pyridine hydrochloride (MPEP). (A) The
incidence of convulsive seizures was significantly reduced in a dose
dependent manner by intraperitoneal (i.p.) injection of MPEP at 25 mg/kg or
40 mg/kg, half an hour prior to audiogenic stimulation, compared to a saline
injected group. The data are presented as percent incidence with 95%
confidence interval and compared using exact logistic regression stratified by
litter. (B) The data are depicted as box and whisker plots (median with
interquartile range, and upper and lower extremes) and analyzed using
Kruskal-Wallis test followed by Dunn’s multiple comparison test. The data
shown in (A,B) are based on the following groups: saline control, n = 17;
MPEP 25 mg/kg, n = 18; and MPEP 40 mg/kg, n = 18. (C,D) Prolonged
epileptiform discharges in hippocampal CA3 pyramidal neurons of slices from
3-week-old 3xTg-AD mice recorded at 60 min after bicuculline perfusion were
suppressed by MPEP (50 µM). Data are presented as mean ± SEM of the five
longest epileptiform discharges from n = 9 slices from n = 5 mice, and
compared using two-way ANOVA followed by Bonferroni post hoc test.
∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001.
bicuculline 20 min, 0.556 ± 0.096 s, vs. bicuculline 60 min,
5.259 ± 0.61 s, n = 9 slices from n = 5 mice; two-way ANOVA
followed by Bonferroni post hoc test, p < 0.01). Within 30 min
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of MPEP (50 µM) perfusion, prolonged epileptiform discharges
were no longer observed and only interictal epileptiform activity
was recorded (Figures 8C,D; average duration of the five longest
epileptiform discharges, bicuculline 60 min: 5.259 ± 0.610 s
vs. bicuculline + MPEP 30 min: 0.526 ± 0.105 s, n = 9 slices
from n = 5 mice; two-way ANOVA followed by Bonferroni
post hoc test, p < 0.01). These results indicate that activation
of mGluR5 sustains ictal-like activity in the hippocampal
CA3 neuronal network of young 3xTg-AD mice.
DISCUSSION
The present study shows that as early as 3 weeks of age,
3xTg-AD mice exhibit high susceptibility to audiogenic
seizures and exacerbated excitability of the hippocampal
CA3 neuronal network. Our work provides evidence that
network hyperexcitability precedes the onset of amyloid plaque
and neurofibrillary pathologies, and memory impairment,
and that intraneuronal human APP/Aβ expression and
mGluR5 activation play a role in this process.
A few studies have previously assessed network
hypersynchrony at young age in AD mouse models. Bezzina
et al. (2015) recently reported the presence of spontaneous
epileptiform activity (interictal spikes), increased susceptibility
to phenylenetetrazole (PTZ, GABAA receptor antagonist)-
induced seizures, and ectopic expression of neuropeptide Y
(NPY, marker of epileptic activity) in the mossy fibers of the
hippocampus at 1.5 months of age (pre-amyloid plaque and
pre-cognitive impairment stage) in Tg2576 mice which harbor
hAPPSWE mutation. Additionally, increased excitability in the
entorhinal cortex of these mice has recently been shown at
2–4 months of age prior to extensive amyloid plaque deposition
(Duffy et al., 2015); these mice were found to have soluble
Aβ40 and Aβ42 in the entorhinal cortex as early as 2 months
of age (Duffy et al., 2015). Another study showed the presence
of interictal spikes on video EEG recordings in Tg2576 mice
at 5 weeks of age (Kam et al., 2016). Increased susceptibility
to PTZ-induced seizures was also reported in 6–8 week-old
TgCRND8 mice (harboring hAPPSWE and hAPPInd mutations)
prior to amyloid plaque pathology and cognitive deficit (Del
Vecchio et al., 2004). The presence of unprovoked electrographic
seizures during 3-week recordings was also reported in the
majority of 3- and 4.5-month-old APdE9 mice (harboring
hAPPSWE and PS1dE9 mutations) prior to amyloid plaque
deposition and cognitive dysfunction (Minkeviciene et al., 2009).
Thus, in recent years, the idea that hypersynchronous network
activity precedes amyloid plaque pathology and cognitive
dysfunction in ADmouse models has become widely recognized.
However, the precise mechanism underlying this network
hypersynchronization leading to precocious epileptic phenotype
remains largely unknown.
In the 3xTg-AD mouse model, used in the current study,
increased excitability in response to brief high-frequency
activation in the hippocampal formation was reported at
4–6 months of age after development of episodic memory
deficit (Davis et al., 2014). In addition, altered Kv2.1 potassium
channel function has recently been shown to mediate increased
excitability in cultured hippocampal neurons (14–19 days
in vitro) from embryonic day 16–18 triple transgenic mice
(Frazzini et al., 2016). To the best of our knowledge, our data
constitute the first clear demonstration of higher sensitivity to
audiogenic seizures and hippocampal CA3 neuronal network
hyperexcitability prior to onset of amyloid plaque deposition,
neurofibrillary pathology, and cognitive deficit in this mouse line
which carries human APP, tau and PS1 mutations.
Audiogenic seizures model human tonic-clonic seizures and
epilepsy (Kandratavicius et al., 2014). Audiogenic seizures are
mediated through brain auditory pathways with initiation in the
midbrain inferior colliculus (Chakravarty and Faingold, 1999)
and the hippocampus (Reid et al., 1983). Aβ pathology in AD
is known to affect central auditory pathway including medial
geniculate body and inferior colliculus nuclei (Sinha et al.,
1993). Previously, increased sensitivity to audiogenic seizures
was reported in 3-week-old Tg2576 (hAPPSWE) and Ts65Dn
(APP triplication) mouse models of AD (Westmark et al., 2010).
Our data show enhanced susceptibility to audiogenic seizures
and reduced latency to the occurrence of convulsive seizures
in 3-week-old 3xTg-AD mice. This seizure susceptibility in
young 3xTg-AD mice was reduced by passive immunization
with an anti-human APP/Aβ antibody or by mGluR5 blockade
suggesting a role of intraneuronal human APP/Aβ prior to
extracellular amyloid deposition and mGluR5 activation in
exaggerated seizure susceptibility in these mice.
The present study shows evidence of enhanced excitability
of the CA3 neuronal network in hippocampal slices from
3xTg-AD mice. Recurrent excitatory synaptic connections
among CA3 neurons provide the cellular substrate for network
synchronized firing (Traub and Wong, 1982; Cherubini and
Miles, 2015) that underlie variant behavioral paradigms (Buzsáki
et al., 1983) or, in conditions of suppressed inhibition,
epileptiform activities (Traub and Wong, 1982, 1983a,b;
Wong and Traub, 1983; Merlin and Wong, 1997; Bianchi
et al., 2012). The hippocampal CA3 circuit is implicated in
encoding spatial representations (O’Keefe and Nadel, 1978) and
episodic memories (Scoville and Milner, 1957). The earliest
neuropathological manifestations in AD are known to occur
in the hippocampus and entorhinal cortex (Belleville et al.,
2008; Reitz et al., 2009; Small et al., 2011). In mild cognitive
impairment (MCI) subjects, CA3 neuronal hyperactivity has
been reported, and dysfunctional encoding mechanisms in
CA3 involved in episodic memory have been implicated (Bakker
et al., 2012, 2015). The present study in 3-week-old 3xTg-AD
mice is the first to document prolonged epileptiform discharges
in CA3 pyramidal neurons in an AD mouse model. Given
the critical role of CA3 auto-association network in episodic
memory, this type of hypersynchronous network activity might
be a contributory factor in hippocampal dysfunction leading to
memory impairment in AD. In fact, recent studies provide strong
evidence for the role of network hypersynchrony in cognitive
impairment. The antiepileptic drug levetiracetam improved
memory performance in MCI subjects (Bakker et al., 2012,
2015), and, in hAPPJ20 mice, suppressed epileptiform activity
and ameliorated memory dysfunction (Sanchez et al., 2012).
As shown in AD mice, early-onset hypersynchronous network
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activity may trigger changes in the hippocampal circuitry,
including remodeling of inhibitory interneuron network, NPY
ectopic expression, and probably aberrant neurogenesis, leading
to progressive deterioration of hippocampal function that
culminates in age-dependent cognitive decline (Palop et al., 2007;
Palop and Mucke, 2009, 2016; Bezzina et al., 2015).
The early-onset epileptic activity in 3xTg-AD mice can be
explained across multiple lines of evidence based on available
literature and our data regarding the mechanism of this activity.
The 3xTg-ADmice carry amutated formof humanAPP resulting
in intraneuronal humanAPP overexpression (3–4 fold), excessive
Aβ peptide production, and its accumulation as amyloid plaques
(Oddo et al., 2003a,b; Billings et al., 2005). Previous studies
and our data show that 3xTg-AD mice are completely devoid
of amyloid plaques at 3 weeks of age (Oddo et al., 2003a,b;
Billings et al., 2005; Oh et al., 2010). This rules out the possibility
that amyloid plaques cause early-onset epileptic activity in these
mice. It was previously reported that the brains of 3-week-
old 3xTg-AD mice contain intraneuronal human APP/Aβ (Oh
et al., 2010), and our immunohistochemical analysis further
confirmed it. Transgenic human APP itself has been suggested
to lead to hypersynchronous network activity in an AD mouse
model (Born et al., 2014). Additionally, Ts65Dn mice which
carry three copies of the APP gene, also exhibit exaggerated
susceptibility to audiogenic seizures as early as 3 weeks of
age (Westmark et al., 2010). APP is a transmembrane protein
which plays critical physiological roles in synapse formation and
maturation (Dawkins and Small, 2014), and altered expression
or processing may lead to network hypersynchronization. APP
is cleaved by β-site APP cleaving enzyme 1 (BACE1). In AD
transgenic mice that overexpress mutant APP, excess levels of
this full-length APP may occupy most of BACE1 enzymatic
activity, thus leading to a decrease in its capacity to process
other substrates, including proteins that regulate ion channel
function and ultimately neuronal excitability. For example,
BACE1 cleaves the Navβ2 subunit of Nav1.1 channels, which
regulates the functional α-subunit expression (Kim et al., 2007)
in parvalbumin-expressing interneurons (Ogiwara et al., 2007).
Alterations in Nav1.1 channels along with inhibitory interneuron
dysfunction culminating in hypersynchronous network activity
and memory impairment was reported in AD mouse models
overexpressing APP/Aβ (Verret et al., 2012; Corbett et al.,
2013). Other data show that loss of the potassium M-current
in hippocampal neurons from BACE1 knockout mice enhances
neuronal excitability and suggest that BACE1 physical association
with the M-current KCNQ channels (Kv7) is required to sustain
its regular function (Hessler et al., 2015). In the present study,
we have not analyzed the membrane current(s) that may be
altered in CA3 hippocampal neurons of young 3xTg-AD mice,
however, consistent with the hypothesis of increased neuronal
excitability resulting from human APP overexpression, our data
indicate that intraneuronal human APP/Aβ leads to network
hypersynchronization and ictal-like activity in this AD mouse
model.
Our data are also consistent with intraneuronal
overexpression of Aβ as a key factor causing enhanced
hippocampal network hypersynchronization and seizure
susceptibility in young 3xTg-AD mice. Intraneuronal Aβ
accumulation was reported to induce hippocampal neuron
hyperexcitability (Scala et al., 2015), which is known to cause
early-onset cognitive dysfunction in 3xTg-AD mice (Billings
et al., 2005). Also, APP Arctic mutation (E693G) transgenic
mice with intraneuronal Aβ accumulation were reported to have
increased susceptibility to PTZ-induced seizures (Ziyatdinova
et al., 2016). We also cannot rule out the presence of soluble
Aβ species and Aβ oligomers in 3-week-old 3xTg-AD mice,
both of which were shown to induce neuronal hyperexcitability
(Minkeviciene et al., 2009; Orbán et al., 2010; Zilberter et al.,
2013). Soluble Aβ was reported to play a critical role in
early-onset hippocampal hyperactivity in double transgenic
(APP23× PS45) AD mouse model (Busche et al., 2012). Overall,
in the present study, because of their intrinsic relationship, we
cannot exclusively separate out the impact of APP from that of
Aβ in inducing early-onset network hypersynchronization in
3xTg-AD mice.
The present study shows that passive immunization with
the anti-human APP/Aβ antibody, 6E10, significantly reduces
intraneuronal transgenic APP/Aβ expression, which leads to
a reduction in hippocampal CA3 hypersynchronous network
activity and seizure susceptibility. The mouse monoclonal
antibody, 6E10, recognizes N-terminal amino acids 1–16 of
Aβ peptide. The passive immunization with 6E10 raises the
possibility that 6E10 primarily acted on the N-terminus of Aβ
in APP full-length and sAPPα on the cell surface and thereby
decreased neuronal excitability. However, the present study also
showed a significant reduction in human APP full-length and
CTFs (APP-CT20) expression. These data indicate that passive
immunization with 6E10 reduced intraneuronal humanAPP/Aβ.
This seems plausible because, besides the N-terminal of Aβ
peptide, 6E10 also recognizes CTFβ/C99 (Chang et al., 2003).
Also, we found a positive correlation between intraneuronal
human APP/Aβ expression, as quantified by either 6E10 or
APP-CT20 antibody in CA3 neurons and ictal-like activity in the
CA3 neuronal network.
Besides APP overexpression and Aβ pathology, the
3xTg-AD mice also exhibit tau overexpression, and tau
hyperphosphorylation and aggregation (Oddo et al., 2003a,b).
In the present study, the role of tau in early-onset network
hyperexcitability was not evaluated and cannot be ruled out.
It was shown that a transgenic mouse model overexpressing
mutant human tau exhibits spontaneous epileptic activity and
seizures with spike-wave complexes in the EEG recordings,
and a higher sensitivity to PTZ (García-Cabrero et al., 2013).
Additionally, reduction of endogenous tau was shown to
ameliorate network hyperexcitability and cognitive impairment
in transgenic APP mice (Roberson et al., 2007, 2011; Warmus
et al., 2014; Hall et al., 2015). Conversely, a recent study
showed that hyperphosphorylated tau reduces hippocampal
CA1 neuronal hyperexcitability via relocation of the axon initial
segment down the axon in P301L tau transgenic mice (Hatch
et al., 2017). Thus, the role of tau in network hyperexcitability in
AD warrants further in-depth evaluation.
Previous studies have shown that group I mGluRs, including
mGluR5, are involved in the induction and maintenance of
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ictal-like activity in an in vitromodel of epileptogenesis (Bianchi
et al., 2012). Agonist stimulation of group I mGluRs was
shown to elicit prolonged epileptiform (ictal-like) discharges
in CA3 neurons of rodent WT hippocampal slices (Taylor
et al., 1995; Merlin and Wong, 1997). However, synaptic
activation of group I mGluRs—as it occurs during short
bursts of glutamate release in slices treated with the GABAA
receptor antagonist bicuculline—is normally not sufficient to
induce prolonged ictal-like discharges in WT slices. Induction
of prolonged ictal-like discharges requires the activation of
group I mGluR-dependent protein synthesis (Merlin et al.,
1998). Sufficient synaptic activation of group I mGluR-
dependent protein synthesis for induction of ictal-like activity
is reached in preparations with gene knockout of translational
repressor molecules (fragile Xmental retardation protein, FMRP;
BC1 RNA; Chuang et al., 2005; Zhong et al., 2009, 2010).
After their induction, synaptic activation of group I mGluRs is
also required to sustain ongoing prolonged ictal-like discharges
(Lee et al., 2002; Chuang et al., 2005; Zhong et al., 2009,
2010; Young et al., 2013). The present study indicates that
prolonged ictal-like discharges in the hippocampal CA3 neuronal
network of 3-week-old 3xTg-AD mice were suppressed by
mGluR5 blockade with MPEP, showing that synaptic activation
of group I mGluRs was sufficient to sustain this ictal-like activity
in the transgenic mice. Also, seizure susceptibility in young
3xTg-ADmice was also suppressed byMPEP.We noted that 3/35
(8.6%) of WT mice showed susceptibility to audiogenic seizures.
We have not explored the underlying cellular mechanisms
in WT. Our data indicate a role of mGluR5 in enhanced
susceptibility to audiogenic seizures in 3xTg-AD mice. The
results cannot determine whether this enhanced excitability is
due to an exaggeration of a precondition to seizures in theWT or
to the emergence of an mGluR-dependent epileptogenic process
in the transgenic mice.
The data in the present study are consistent with mGluR-
dependent hyperexcitability associated with APP overexpression.
In the FXS mouse model (Fmr1 knockout), absence of
the translational repressor FMRP results in elevated APP
levels (Westmark and Malter, 2007), and normalization of
elevated APP levels by App knockdown reduces MPEP-sensitive
ictal-like discharges in CA3 (Westmark et al., 2016) as well
as audiogenic seizures (Westmark et al., 2011). The possible
mechanism(s) by which APP/Aβ overexpression may increase
mGluR-hyperexcitability were not directly investigated in the
present study. As mentioned before, high levels of full-length
APP may indirectly increase neuronal excitability by altering
BACE1-dependent regulation of currents that are modulated by
mGluRs. For example, the potassium M-current is decreased
by reduced availability of BACE1 (Hessler et al., 2015) and
is suppressed by mGluR activation (Charpak et al., 1990).
These effects may be additive in the transgenic mice resulting
in larger depolarization and prolonged firing. Another study
shows that intracellular APP/Aβ overexpression results in
extracellular levels of soluble Aβ oligomers (Aβo) that are
sufficient to bind to the cellular prion protein (PrPC) and
activate mGluR5 (Um et al., 2013). Such binding has been
shown to induce inward currents in transfected oocytes and
intracellular calcium increase in cultured cortical neurons (Um
et al., 2013).
In summary, the present study shows that seizure
susceptibility and hypersynchronous network activity precedes
amyloid plaque pathology and memory dysfunction in 3xTg-AD
mice. This early-onset network hyperexcitability can be
suppressed by passive immunization with an anti-human
APP/Aβ antibody and mGluR5 antagonist, MPEP. The
early-onset network hyperexcitability can culminate in
progressive modifications in hippocampal circuitry, ultimately
contributing to memory impairment in AD mice. In humans,
hypersynchronous network activity could potentially be used as
a biomarker to predict memory decline. Additionally, the present
study provides rationale for employing Aβ passive immunization
at early human AD stages to exert maximal beneficial effect.
The mGluR5 antagonists need to be further evaluated for their
beneficial effect on network hyperexcitability, and potentially on
cognitive dysfunction in AD.
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